OpenVSafe by OpenVAERS
Search V-safe

FRQ-31816-26804

3 vaccinations 5 coded responses 30 check-ins 5 free-text entries 0 call cases
Sex
Female
Age at first dose
46-50
ZIP prefix
941 / CA
Registered
2021-01-21
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-20
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-21
    Registered in v-safe
  3. 2021-01-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-01-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-01-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache
    Adult check-in
  6. 2021-01-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-27
    Health check-in — day 7, dose 1
    Feeling: Good · Headache
    Adult check-in
  10. 2021-02-03
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-02-10
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-02-13
    Dose 2 — Pfizer-BioNTech
  13. 2021-02-13
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  14. 2021-02-14
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness
    Free text: Enlarged axillary lymph node of the associated arm (left)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-02-15
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Fever · Fatigue or tiredness
    Free text: Enlarged left axillary lymph node (associated injection side)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-02-16
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain
    Free text: Enlarged axillary lymph node
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-02-17
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain
    Free text: improved axillary lymph node enlargement
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-02-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-02-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-02-20
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-02-27
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-06
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-13
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-03-20
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-03-27
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-05-15
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-08-16
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-10-13
    Dose 3 — Pfizer-BioNTech
  29. 2021-11-06
    Survey response — day 21, dose 3
    MedDRA: Chills, Fatigue, Hyperhidrosis, Lymphadenopathy, Myalgia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: At the 24-36 hours post 3rd vax I experienced enlarged axillary lymph nodes (left arm vaccine was given), chills, sweating, fatigue and muscle aches for that period. At the 36 hour point, most of the symptoms resolved with the axillary ln reducing.
    MedDRA releases: 2024-11 · check-in free text available
  30. 2021-11-10
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  31. 2021-11-17
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  32. 2021-11-24
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  33. 2022-01-12
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  34. 2022-04-13
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-20Pfizer-BioNTech
22021-02-13Pfizer-BioNTech
32021-10-13Pfizer-BioNTech No

Free text

Release 4 — days 1–6 daily, dose 2

2021-02-14

Systemic reaction (other): Enlarged axillary lymph node of the associated arm (left)

2021-02-15

Systemic reaction (other): Enlarged left axillary lymph node (associated injection side)

2021-02-16

Systemic reaction (other): Enlarged axillary lymph node

2021-02-17

Systemic reaction (other): improved axillary lymph node enlargement

Release 10 — day 21, dose 3

2021-11-06

Symptoms: At the 24-36 hours post 3rd vax I experienced enlarged axillary lymph nodes (left arm vaccine was given), chills, sweating, fatigue and muscle aches for that period. At the 36 hour point, most of the symptoms resolved with the axillary ln reducing. cut off by CDC

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDChills · · ✓
SDFatigue · · ✓
SDHyperhidrosis · · ✓
SDLymphadenopathy · · ✓
SDMyalgia · · ✓
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release